ticker
Login
business news
Politics And Regulation
Markets
The Economy
Editor's Pick
trading and investing
Stocks
ETFs
Fixed Income
Earnings
Currencies
Commodities
Options
Taxes
Personal Finance
How To Trade
How To Invest
sectors
Biotech/pharma
Consumer
Energy
Financial
Global Markets
Media
Precious Metals
Real Estate
Technology
Transportation
special features
Wall Of Worry
Random Thoughts
Sports Business
Minyanville Press
Video
Hoofy & Boo
Radio
MV PREMIUM
subscriptions
Launch Buzz And Banter
Buzz And Banter
Elliott Wave Insider
Tchir's Fixed Income Report
Cooper's Market Report
Techstrat Report
Optionsmith
The Stock Playbook
Ad Free Minyanville
Minyanville Book Store
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
GlaxoSmithKline PLC ADS
(NY:
GSK
)
52.94
USD
UNCHANGED
Official Closing Price
/ Updated:
6:40 PM EDT, May 22, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about GlaxoSmithKline PLC ADS
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Pfizer takes its shot at a vaccine for evasive superbug
Today 1:20 EDT
Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year...
Read More
from
FOX News
GlaxoSmithKline: The Winning Streak Continues (GSK)
May 21, 2013
from
Comtex SmarTrend® News Briefs
GSK Says Lowering Prices in China Caused Higher Sales
May 21, 2013
Want to increase revenues in China? You might try lowering prices. It seems to have worked for GlaxoSmithKline. In 2009, the company reduced the cost of its allergy treatment, Avamys nasal spray. The...
Read More
from
ChinaBio® Today
Impax board steps in to oversee Hayward manufacturing issues
May 20, 2013
category
Management
,
Biotech
,
GlaxoSmithKline
, and 9 more.
from
Financial Content
UBS Survey Shows Signs of Strength for Gilead's (GILD) TAF
May 17, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8350777 for the full story.
Read More
from
StreetInsider.com News Articles
Chief executives and the itch to quit
May 16, 2013
LONDON, May 16 (Reuters) - On approaching his 60th birthday this year, long-serving Tullow Oil boss Aidan Heavey told staff he felt "like two 30 year-olds".
Read More
category
companyNews
from
Reuters: Company News
Buffett's Berkshire Hathaway Enters Chicago Bridge & Iron (CBI), Sells Archer-Daniels-Midland (ADM), General Dynamics (GD)
May 15, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8343832 for the full story.
Read More
from
StreetInsider.com News Articles
19 Foreign Stocks With Cheap Valuation And Good Yields
May 15, 2013
category
Unassigned
,
Gold & Silver
from
Trefis
Companies receiving the most NC tax breaks
May 14, 2013
category
Time Warner Cable
,
Target
,
Cree
, and 11 more.
from
Financial Content
Market Wrap: Retail Sales Rip in April; Theravance, Elan Enter $1B Deal; Petrobras' Record Debt Sale
May 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8332964 for the full story.
Read More
from
StreetInsider.com News Articles
US STOCKS-Wall St ends near flat after recent gains; healthcare climbs
May 13, 2013
NEW YORK, May 13 (Reuters) - U.S. stocks ended flat on Monday, pausing after hitting record highs last week, but strength in healthcare issues helped to keep declines in check.
Read More
category
companyNews
from
Reuters: Company News
US STOCKS-Wall St near flat after recent gains; retail data helps
May 13, 2013
NEW YORK, May 13 (Reuters) - U.S. stocks were little changed on Monday as investors stepped back following last week's new highs, but stronger-than-expected retail sales data limited declined.
Read More
category
companyNews
from
Reuters: Company News
Notable 52-Week Highs and Lows of the Day 05/13: (TSLA) (THRX) (FSLR) High; (GNVC) (ANV) Low
May 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8331715 for the full story.
Read More
from
StreetInsider.com News Articles
US STOCKS-Wall St flat after retail sales, Nasdaq edges higher
May 13, 2013
* Indexes: Dow down 0.2 pct, S&P up 0.1 pct, Nasdaq up 0.3 pct
Read More
category
companyNews
from
Reuters: Company News
US STOCKS-Wall St dips but rise in retail sales limits decline
May 13, 2013
NEW YORK, May 13 (Reuters) - U.S. stocks edged lower on Monday as investors paused following a rally that took indexes to record highs, though a strong read on retail sales limited declines.
Read More
category
companyNews
from
Reuters: Company News
US STOCKS-Wall St dips but rise in retail sales limits decline
May 13, 2013
* Elan to buy part of U.S. drug firm Theravance's royalty for $1 billion
Read More
category
companyNews
from
Reuters: Company News
StreetInsider.com Pre-Open Movers 5/13: (THRX) (MTSN) (TSLA) Higher; (AFFY) (CEL) (UNXL) Lower (more...)
May 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8330435 for the full story.
Read More
from
StreetInsider.com News Articles
US STOCKS-Wall St set to dip at open after record high
May 13, 2013
NEW YORK, May 13 (Reuters) - U.S. stocks were poised for a lower open on Monday after the S&P 500 index closed at a record high, but an unexpected rise in retail sales last month was likely to curb any...
Read More
category
companyNews
from
Reuters: Company News
Late payment costs European companies 350 billion euros
May 13, 2013
European companies lost 350 billion euros ($450 billion) last year due to late or unpaid bills, underlining fears that small businesses expected to drive economic recovery are faltering in a prolonged...
Read More
from
FOX News
US STOCKS-Futures dip after record high; retail sales on tap
May 13, 2013
NEW YORK, May 13 (Reuters) - U.S. stock index futures dipped on Monday, indicating the S&P 500 may retreat from its most recent record high, ahead of monthly retail sales data.
Read More
category
companyNews
from
Reuters: Company News
US STOCKS-Futures dip after record high; retail sales on tap
May 13, 2013
NEW YORK, May 13 (Reuters) - U.S. stock index futures dipped on Monday, indicating the S&P 500 may retreat from its most recent record high, ahead of data on retail sales.
Read More
category
companyNews
from
Reuters: Company News
Theravance (THRX), Elan (ELN) Enter $1B Royalty Participation Agreement
May 13, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8329519 for the full story.
Read More
from
StreetInsider.com News Articles
UPDATE 2-Elan strikes $1 bln royalty deal with Theravance
May 13, 2013
* Elan to acquire newly approved Breo as part of $1 bln deal
Read More
category
companyNews
from
Reuters: Company News
UPDATE 1-Elan strikes $1 bln royalty deal with Theravance
May 13, 2013
* Elan to acquire newly approved Breo as part of $1 bln deal
Read More
category
companyNews
from
Reuters: Company News
Glaxo, Theravance Confirm BREO ELLIPTA Gained US FDA Approval for Treatment of COPD
May 10, 2013
GlaxoSmithKline plc (NYSE: GSK ) and Theravance, Inc. (NASDAQ: THRX ) today announced that the US Food and Drug Administration (FDA) has approved BREO(TM) ELLIPTA(TM) as an inhaled long-term,...
Read More
category
Benzinga
,
THRX
,
News
, and 2 more.
from
Latest Articles from Benzinga.com
Streetinsider.com's Hot Lunchtime Reads 05/10: (WCRX) (AMRN) ((NVDA) (TSLA) (DIS)
May 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8326926 for the full story.
Read More
from
StreetInsider.com News Articles
FDA approves COPD drug from Theravance, GSK
May 10, 2013
category
Theravance Inc/
,
Rick Winningham
,
Health Care
, and 4 more.
from
Financial Content
GlaxoSmithKline PLC (GSK), Theravance (THRX) Higher After FDA Approval for Breo Ellipta
May 10, 2013
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=8326623 for the full story.
Read More
from
StreetInsider.com News Articles
Merck And Glaxo Drop HPV Vaccine Price To Reach Girls In The Developing World
May 09, 2013
Of the 270,000 annual deaths from cervical cancer, 85% happen in the developing world, where Pap smears and viral DNA testing are not available to catch cancer or pre-cancer early.
Read More
category
NYSE:MRK
,
NYSE:GSK
,
LONDON:GSK
from
Forbes Real Time
Another Disappointing Study For Fish Oil Supplements
May 08, 2013
Another large study has failed to find any benefits for fish oil supplements. The Italian Risk and Prevention Study, published in the New England Journal of Medicine, enrolled 12,513 people who had not...
Read More
category
NYSE:GSK
,
NASDAQ:AMRN
from
Forbes Real Time
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Stay Connected
WHAT'S POPULAR IN THE VILLE
1
Random Thoughts: A Signal That Bears Watching
Todd Harrison
2
Random Thoughts: The Chasm Between Stocks and Commodities Continues to Widen
Todd Harrison
3
1929, 1987, and 2013: Three of a Kind?
Jeffrey Cooper
4
As Markets Soar Into Unknown Territory, Collar Profits With the S&P 500
Oliver Pursche
5
The 10 Trading Commandments
Todd Harrison
See All Articles
»
Financial Product Guide